Medicamen BiotechMEDICAMEQ 
$5.57-1.82%24h
-1.82%24h
Global rank23209
Market cap$69.45M
Change 7d11.47%
YTD Performance-23.25%
SP500 benchmarkUnderperform
P/E0.47
P/S4.14
Revenue$16.79M
Earnings$1.76M
Dividend yield-
Main Sector
Healthcare
Category
Medicamen Biotech (MEDICAMEQ) Total Liabilities
MEDICAMEQ Total Liabilities in 2022: $10.15M
According to Medicamen Biotech latest financial reports the total liabilities of MEDICAMEQ is $10.15M, an increase of 7.42% to 2022. At the end of 2022 company had $9.44M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Medicamen Biotech is responsible for during its operational activities.
Medicamen Biotech (MEDICAMEQ) Total Liabilities History from 2023 to 2022
-
Value:-
MEDICAMEQ Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $10.15M | 7.42% |
| 2022 | $9.44M | 30.23% |
| 2021 | $7.25M | 1.28% |
| 2020 | $7.16M | 41.88% |
| 2019 | $5.05M | - |
View the Top Total Liabilies Stocks
